Harm-Reduction

Carney should embrace harm reduction for smokers

Liberal Leader Mark Carney is out to prove he’s a centrist. By ending unpopular Trudeau-era policies like the capital gains tax hike and the consumer carbon tax, Carney is clearly making a play for the political middle. 

If Carney really wants Canadian consumers to believe he’s moved to the middle, it’s time for the Liberals to embrace evidenced-based policies. That includes pivoting away from the last government’s approach to nicotine pouches. 

Former health minister Mark Holland banned certain flavours of nicotine pouches and restricted the sale of pouches that are still allowed to be sold to being behind pharmacy counters. 

From a harm-reduction standpoint, these moves make zero sense. 

First, policy makers should want smokers to make the shift from smoking cigarettes to cessation products like nicotine pouches. If including more flavours encourages that transition, it simply doesn’t make sense to block it. 

Plus, Nicorette, which is yet another smoking cessation product,comes in gums, lozenges and sprays and offers a variety of flavours, including mint, fresh fruit, cool berry and mild spearmint.

Why allow Nicorette to come in all kinds of flavours but ban most of those flavours for pouches? The U.S. Federal Drug Administration sensibly took the opposite approach and approved 20 flavours of nicotine pouches.  

Second, under present rules, folks can still buy cigarettes at virtually every corner store and gas station, but they’ve got to go to a pharmacy to buy a product that actually helps smokers quit and significantly reduces harm for users. 

Why allow cigarettes to be sold at gas stations and corner stores but not nicotine pouches? 

It’s important to remember that it’s combusting tobacco, not nicotine, that is having such a damaging impact on Canadians’ health. If Canadian consumers want to be able to purchase products with nicotine instead of buying cigarettes, it simply doesn’t make sense to make it easier for consumers to access more harmful products than smoking cessation tools. 

Critics of nicotine pouches argue that pouches are a gateway to smoking. However, the evidence simply doesn’t bear that out. 

The German Federal Institute for Risk Assessment found that pouches have very limited appeal (11-12%) to people who have never consumed tobacco products before, including minors. 

Among smokers, by contrast, or those who chew tobacco, interest in nicotine pouches  increases to 75%. 

This shouldn’t be a shocking statistic: most smokers spend decades trying to quit. Given that pouches offer a possible off-ramp that is far less risky for one’s health than smoking, it makes perfect sense that smokers would be highly interested in nicotine pouches. 

At the same time, the German Federal Institute of Risk Assessment also found that nicotine pouches carry little risk and are just as risky as other forms of cessation tools, including nicotine patches, gums and sprays. According to that assessment, nicotine pouches are 99% less harmful than cigarettes.  

Pouches are less risky than smoking and the vast majority of those interested in nicotine pouches are those who presently smoke. These products should be made easier for folks to access, not harder. And yet that’s exactly the approach that the Trudeau government took under Holland as health minister. 

Then there’s the risk of the black market: If consumers are determined to access nicotine pouches to help them quit smoking, there’s every risk that scores of Canadians will turn to the black market. Contraband tobacco is a huge issue in Canada. Why encourage consumers to seek out the black market for smoking cessation products? The black market allows for zero government regulation, whereas the government could enact sensible regulations regarding nicotine pouches by treating them as smoking cessation tools. 

Carney wants Canadians to believe he’s a middle-ground, evidence-based politician bringing the Liberals back to the middle of the political spectrum. If that’s true, Carney should take a hard look at the previous Liberal government’s approach to nicotine pouches and prioritize smoking cessation by making these products easier — not harder — to access. 

Originally published here

Why is the government paying to lobby itself? It’s time to end this corrupt process

Donald Trump sent shockwaves through the U.S. NGO ecosystem with his executive order which pauses federal funding, pending review, for organizations that are deemed to be “undermining national security.” What falls in this category is opaque, but generally speaking, the premise is that funding is paused until the Trump administration can review how money is being spent, specifically to ensure they aren’t using taxpayer money to fund organizations that undermine Trump’s policies. Regardless of what you might think of President Trump, the logic of this does make sense.

Ironically enough the same issue is also making headlines in Europe right now as well, where the European Commission has conceded that public funds have been used to fund NGOs who turn around and lobby MEPs for policy change.

Why does this matter for Canada? Well, it matters because we have this very same problem here in Canada, especially when it comes to public health lobbying.

In October, the self-appointed guardians of public health, Physicians For A Smoke-Free Canada, marched on Parliament Hill, demanding the resignation of Ya’ara Saks, minister of addictions, for her alleged failure to crack down on the vaping industry. They called for an end to all flavoured vapes, insisting that only tobacco flavour should be permitted, despite the fact that smokers trying to quit overwhelmingly rely on flavours to ditch cigarettes. Making vapes taste like the product people are trying to quit is a ludicrous proposition if there ever was one. Why should a product without tobacco mimic its noxious flavor, especially when it’s meant to help smokers quit, and 95 percent less harmful than smoking?

From the perspective of harm reduction, their crusade is a regressive misstep. The very essence of vaping is to provide an alternative to smoking, not to replicate its sensory experience. Yet, these activists, armed with myths about vaping’s efficacy in smoking cessation, push for policies that would make quitting harder, not easier.

The irony here is as thick as the smoke they seek to banish. Organizations like Physicians for a Smoke-Free Canada, which one might think would celebrate any smoke-free alternative, are curiously funded by the government, in an almost identical way as in Europe. In a dance of circular lobbying, this group, receiving up to 95 percent of its funding from public coffers, lobbies the same government for policy changes. This is not charity; this is an orchestrated echo chamber where taxpayer money funds the very advocacy that seeks to control taxpayer behaviour.

What we see here is not just a waste of public funds but a perversion of democracy. When the government pays to lobby itself, it erodes the independence of civil society, manipulates public discourse, and masks political maneuvering as public health advocacy. In 2022, Physicians for a Smoke-Free Canada, with more than half its revenue spent on just twoemployees’ salaries, exemplifies this corrupt process.

This circular “sock puppeting,” a term coined by Christopher Snowden at the Institute for Economic Affairs in London, isn’t limited to one organization, on one issue. Take the example of nicotine pouches, which don’t contain tobacco, don’t cause cancer, and are shown to not only be a useful tool to quit smoking but are also 99 percent less harmful than cigarettes. The Canadian Cancer Society, which received more than $27,000,000 from taxpayers in 2024, actively lobbied for heavy restrictions on this smoking cessation tool. Yes, the Canadian Cancer Society, while getting millions from taxpayers, turned around and lobbied Ottawa to restrict access to a product that doesn’t cause cancer.

Unfortunately, the same old song rings true on alcohol policy as well, where organizations historically tied to the prohibition movement peddle exaggerated risks about moderate alcohol consumption, again with you, the taxpayer, footing the bill for it.

The real scandal isn’t vape flavours, nicotine pouches, or alcohol-related pseudoscience; it’s the systemic corruption where the government funds its own critics to push policies against the public’s actual interest. This is not about health; it’s about control, disguised in the garb of concern. We should not, as taxpayers, fund our own fun policing, especially when it comes to the personal choices of adults.

This practice of self-lobbying must end. It’s unlikely to be ended by this government, especially with its narrowing shelf life, but it should be ended by the next. If Pierre Poilievre becomes Canada’s prime minister after the next election, he’ll have a fiscal mess to clean up, and circular lobbying should be one of the first cuts made. It’s time to call out these “sock puppets” for what they are—the fun police, funded by our own money, to limit our freedoms under the guise of protecting us.

Originally published here

Ottawa Needs To Rethink Its Smoking Fight

The third week of January, marked as National Non-Smoking Week, arrives every year with great sanctimony but without much action to back it up. Canada, despite this week coming and going every year, continues to have a significant number of smokers. As of 2022, 10.2 per cent of Canadians still partake in the ritual of lighting up. This revelation should provoke not just a week of platitudes but an urgent reevaluation of our strategies.

Our approach to smoking cessation is not merely deficient; it’s a deliberate exercise in self-sabotage. The Canadian government, in its infinite wisdom or perhaps infinite folly, has chosen to ignore the potential of reduced risk products like vaping, nicotine pouches, and heat-not-burn devices. Compare this to Sweden, with a more enlightened policy on harm reduction, where the smoking rate is just slightly above 5 per cent.

For those who’ve tried to quit smoking, the experience is brutal and painstaking. Quitting isn’t just a matter of willpower; it’s about offering viable alternatives. Sweden has shown the way by embracing products that allow smokers to transition from the consequences of combustion to something far less harmful.

Yet, Ottawa, in its bureaucratic zeal, has systematically erected barriers against these life-saving transitions. Take nicotine pouches, for instance. German researchers have found them to be 99% less harmful than cigarettes, yet Health Minister Mark Holland has seen fit to limit their flavors to mint or menthol and ban their sale alongside cigarettes in stores. This policy demonstrates a bizarre logic where corner stores can be trusted with the sale of cigarettes but not with these safer alternatives. The dissonance here is as thick as the smoke the Minister so passionately wants to vanish. 

Contrast Mark Holland’s view with that of his former international colleagues. There is a long list of former health regulators who agree that these are useful as a quitting tool, including the former head of the U.S. FDA Scott Gotlieb, saying “we have to embrace them and offer adult smokers modified risk products”. That fact is in large part why the FDA approved Zyn in the United States, in 20 flavours, as a smoking cessation tool 

The hypocrisy doesn’t end with pouches. The war on vaping, which Public Health England has shown to be 95% less harmful than smoking, continues unabated. Flavour bans loom, despite evidence from a study of over 17,000 Americans demonstrating that flavoured vaping products significantly increase the likelihood of quitting smoking. Ottawa’s approach seems designed to ensure we never actually achieve the goals of National Non-Smoking Week. 

But it doesn’t end there either, unfortunately. Heat-not-burn products, which avoid the harmful combustion of tobacco, have been endorsed by the FDA, and shown to reduce harm by 90%. 

Yet, Canada’s tax regime treats these products the same as traditional cigarettes. The excise “sin tax” demands a minimum of 50 grams for stamps, meaning a 5.33-gram pack of heat-not-burn units is taxed the same amount as a package containing 50 grams. That means Canadians are paying this sin tax at nine times more than the regular rate, and three times more than a pack of twenty traditional cigarettes. How can Canadians looking to switch to a less harmful product rationalize such a cost? This is a moral failing that punishes those seeking less harmful options.

The purpose of the sin tax on traditional cigarettes is to discourage people from purchasing them, and of course to raise money for the government. However, if it is proven that heat-not-burn products reduce harm to the smoker, and potentially acts as a way for people to transition away from smoking, then the purpose of the tax no longer makes sense for heat-not-burn. 

Canada faces a stark choice: follow Sweden’s lead or continue this charade of public health concern while the smoking rates remain stubbornly high. The evidence is before us, the success stories are clear, but only if we have the intellectual honesty and moral courage to act on them. Otherwise, National Non-Smoking Week will remain a hollow gesture, a week where we pat ourselves on the back while we accomplish very little. 

Bloomberg’s harmful interference in Vietnam threatens smoking reduction

Written by Alberto Gomez Hernandez, Policy Manager at the World Vapers Alliance

Vietnam is at a turning point in its fight against smoking. With over 17 million smokers and over a hundred thousand lives lost to smoking-related illnesses annually, the stakes couldn’t be higher. Yet, instead of adopting proven harm reduction strategies to help smokers quit, Vietnam passed a law in late November to introduce harmful bans on vaping and heated tobacco products after facing intense pressure from Bloomberg Philanthropies and its allies.

Bloomberg Philanthropies, led by Michael Bloomberg, has been a leading force behind global anti-vaping campaigns. While it claims to act in the name of public health, its policies often undermine harm reduction efforts and leave smokers with no viable alternatives to quit. Even more troubling is Bloomberg’s outsized influence over the World Health Organization (WHO), which pushes an anti-vaping agenda that ignores scientific evidence and fails to serve the public health interests of countries like Vietnam.

WHO and Bloomberg: An alliance of hypocrisy

The WHO, heavily funded by Bloomberg Philanthropies, has consistently advocated for restrictive policies on vaping and other harm reduction tools. This influence has led to a one-fits-all prohibitionist approach that disregards the needs of different individuals and countries. In Vietnam, this alliance has manifested in pressure to establish bans on vaping and heat-not-burn, depriving millions of smokers of access to less harmful alternatives.

The hypocrisy of this relationship was recently highlighted in a Facebook post that revealed how officials from the World Health Organisation’s office in Vietnam thanked Bloomberg’s organizations for its generous support, who allegedly allowed them to provide technical assistance to the government to combat smoking and the uptake of other nicotine products. At the same time, the government has ignored the voices of millions of users of e-cigarettes in the country that managed to quit smoking thanks to these new devices. While they publicly demonize harm reduction tools, they fail to address the core issues of smoking and its devastating health impacts.

The push from Bloomberg Philanthropies and the WHO represents a form of regulatory colonialism, where foreign entities dictate policies without considering the unique challenges of individual countries. Vietnam deserves the autonomy to craft policies that prioritize the health and well-being of its people, not the agendas of external organizations.

The costs of prohibition

Prohibitionist policies, like those pushed by Bloomberg and the WHO, often backfire. In countries where vaping is banned or heavily restricted, consumers turn to unregulated black-market products, which lack safety standards and pose greater risks. These products are potentially dangerous and can bring higher costs to the Vietnamese healthcare system. When users do not turn to these products, they switch back to smoking, increasing the burden of smoking-related illnesses on the state budget. On the other hand, countries like the UK, Sweden, and New Zealand have demonstrated that regulating safer alternatives and promoting them as less harmful can reduce smoking rates, lower costs and ultimately save lives.

The Case for Harm Reduction in Vietnam

Harm reduction works. In Sweden, the adoption of snus—a safer nicotine alternative—has led the country to the brink of becoming the first smoke-free nation in the world. The United Kingdom and New Zealand have seen significant reductions in smoking rates by embracing vaping as a tool for quitting. These success stories show that evidence-based policies save lives.

Vietnam could follow this path. By regulating vaping and heated tobacco products, the government can provide smokers with safer options, reduce tobacco-related deaths, and alleviate the strain on its healthcare system. Regulation ensures product safety, restricts access for minors, and encourages adult smokers to make healthier choices.

It’s time for Vietnam to reject harmful foreign interference and embrace policies that put its citizens first. By adopting harm reduction strategies, Vietnam can lead the way in Southeast Asia and show the world that progress is possible when science and public health take precedence over ideology and hypocrisy.

Justices Skeptical of FDA’s Actions on Vapes

The hearing took just over an hour. Today, the United States Supreme Court heard oral arguments in FDA v. Wages and White Lion Investments, LLC, a pivotal case concerning the Food and Drug Administration’s rejection of applications to market flavored nicotine vaping devices.

The case is about much more than saving the vaping industry; it is also a landmark case for regulatory accountability related to public health and consumer choice. A decision is expected by the end of the Supreme Court’s term in June.

At issue is whether the FDA acted arbitrarily and capriciously when denying numerous premarket tobacco product applications (PMTA), as alleged by the manufacturers and affirmed by the U.S. Court of Appeals for the 5th Circuit, which accused the FDA of a “regulatory switcheroo”. 

Elizabeth Hicks, US Affairs Analyst of the Consumer Choice Center, stated that the case underscores the need for “fairness and transparency” in regulatory processes. “The FDA’s blanket denials have placed enormous hurdles on firms providing harm-reduction alternatives, potentially decimating an industry that millions of adult consumers rely on to transition away from smoking traditional cigarettes,” she said.

Read the full text here

Puzzling pouch priorities of public health

This week Sweden edged closer to officially becoming “smoke free.” According to the World Health Organization, that is a smoking rate lower than 5%. At 5.3%, and on the current trajectory, it’s not a matter of if Sweden becomes smoke free, but when. As one would expect, Sweden is the only country in Europe where lung cancer isn’t at the top of the list for cancer mortality. 

In Canada, by contrast, lung cancer is the leading cancer killer. Canada has set an ambitious target of cutting the amount of smokers to less than 5% by 2035, which would mean going from 4.6 million Canadian smokers in 2022 to fewer than 1.8 million Canadian smokers in 2035. 

A noble goal, then.

However, as anyone who is a smoker and has tried to quit will likely attest, quitting smoking is extremely difficult and not always a case of quitting cold turkey. 

Therefore one way to encourage quitting smoking includes transitioning to products that are less harmful than traditional cigarettes.

Unfortunately however, Ottawa, at every step, has made it harder for smokers trying to quit through a myriad of bad policies.

Take nicotine pouches. Despite the fact that they are 99% less harmful than cigarettes, according to German researchers, Health Minister Mark Holland has restricted available flavours to just mint/menthol, and banned pouches from being sold alongside cigarettes. 

The cognitive dissonance here is rather astounding. In Holland’s view, corner stores can be trusted to sell cigarettes, specifically not selling them to minors, but they can’t be trusted to sell an exponentially less risky product like pouches? There is a long list of former health regulators who agree that these are useful as a quitting tool, including the former head of the U.S. FDA Scott Gotlieb, saying “we have to embrace them and offer adult smokers modified risk products”.

The hypocrisy of course isn’t limited to pouches. It also includes Ottawa’s approach to vaping. 

Ottawa seems hellbent on following through on the promise to ban vape flavours, despite the fact that vaping is 95 per cent less harmful than smoking, according to Public Health England. Their research shows that given its success, public health messaging should encourage smokers to make the switch, not make it harder. 

South of the border, a nationally representative longitudinal study of over 17,000 Americans showed that adults who used flavoured vaping products were 2.3 times more likely to quit smoking cigarettes when compared to vapers who consumed tobacco-flavoured vaping products. Continuing the war on vaping all but ensures Canada will never meet its 5 per cent target by 2030.

And it doesn’t end there either, unfortunately. Heat-not-burn products, which heat tobacco rather than combust it, have been shown to reduce the harm of intoxicants by around 90 per cent when compared to cigarettes.

The USA’s FDA has gone as far as to authorize marketing these products as a product that “significantly reduces the production of harmful and potentially harmful chemicals”.

However, the Canadian government is not making that transition easy for Canadians either. Rather than lend an encouraging hand to those who would like to be a part of their ambitious 2035 goal, the government taxes these products the same way they do traditional cigarettes.

The purported use of “excise stamps” — in actuality a sin tax— on traditional cigarettes is to discourage people from purchasing this harmful product, and of course to raise money for the government. However, if it is proven that heat-not-burn products reduce harm to the smoker and potentially acts as a way for people to transition towards quitting smoking, then the purpose of the tax no longer makes sense.

The current excise sin tax demands a minimum of 50 gram excise stamps. This tax means that tobacco in a twenty-pack of heat-not-burn units which weighs 5.33 grams is taxed the same amount as a package containing 50 grams. That means Canadians are paying this sin tax at nine times more than the regular rate, and three times more than a pack of twenty traditional cigarettes. 

How can Canadians looking to switch to a less harmful product or who wish to quit smoking rationalize such a cost? It would certainly seem to run counter to the Canadian government’s attempt to curb smoking by 2035.

At the end of the day Canada has to make a decision: do we want to follow Sweden’s lead and meet the target we’ve set for ourselves or not? The playbook for success is there, but only if we have the willingness to see what is right in front of us.

Originally published here

SCOTUS Skeptical of an FDA Acting Arbitrarily Against Vape Products

Washington, D.C. – The U.S. Supreme Court today heard oral arguments in FDA v. Wages and White Lion Investments, LLC, a pivotal case concerning the Food and Drug Administration’s rejection of applications to market flavored nicotine vaping devices.

This is a landmark case for regulatory accountability related to public health and consumer choice.

At issue is whether the FDA acted arbitrarily and capriciously when denying numerous premarket tobacco product applications (PMTA), as alleged by the manufacturers and affirmed by the U.S. Court of Appeals for the 5th Circuit, which accused the FDA of a “regulatory switcheroo”. 

Elizabeth Hicks, US Affairs Analyst of the Consumer Choice Center, observed today’s arguments and weighed in on the consequences of the case for consumers,

“This case underscores the need for fairness and transparency in regulatory processes. The FDA’s blanket denials have placed enormous hurdles on firms providing harm-reduction alternatives, potentially decimating an industry that millions of adult consumers rely on to transition away from smoking traditional cigarettes.”

Advocates of prohibition on flavored e-liquids, including groups like the American Medical Association, have characterized these products as targeting youth rather than adult consumers. Arguments in front of SCOTUS focused on whether the FDA had been transparent and consistent in why product applications were denied and what was lacking in the marketing plans of the applicants.

Associate Justice Clarence Thomas observed that the FDA guidance was indeed “a moving target” that shifted throughout the process, while Associate Justice Neil Gorsuch lamented that applicants where not granted conditions for jury trials in administrative cases, as the Court outlined in SEC v. Jarkesy.

Hicks continued, “The FDA’s rejection of Triton and Vapetasia’s applications demonstrates a failure to balance or even understand public health priorities and opportunities provided by less harmful nicotine products. While we all agree on the need to keep these products out of the hands of young people, denying adult smokers access to safer alternatives like flavored vaping devices could have dire consequences for harm-reduction efforts. Regulatory decisions should be evidence-based, not rooted in unachievable or shifting standards that are unreasonable to provide.”

The Consumer Choice Center calls on policymakers and regulators to prioritize consumer access to safer alternatives and ensure regulatory clarity around nicotine products. 

###


The Consumer Choice Center is an independent, nonpartisan consumer advocacy group championing the benefits of freedom of choice, innovation, and abundance in everyday life for consumers in over 100 countries. We closely monitor regulatory trends in Washington, Brussels, Ottawa, Brasilia, London, and Geneva.

Find out more at www.consumerchoicecenter.org

Why does Ottawa pay groups to lobby … Ottawa?

Last Friday, anti-vaping activists took to Parliament Hill and called for the resignation of Minister of Addiction Ya’ara Saks. They said they’ve been waiting 14 months for the minister to “strengthen controls” on vaping and she has not delivered. Their main grievance is that vaping products are flavoured, and they repeated their call for all vape flavours to be banned.

This would be a huge step backward in harm reduction. According to the anti-vapers, vape products should only be tobacco-flavoured. On its face this is ridiculous. Why make a product that doesn’t contain tobacco taste like tobacco? And from the standpoint of smokers trying to quit, which many vapers are, why would the government want to limit vapers’ access to only one flavour — which tastes like the product they are trying to quit altogether?

Even stranger than these organizations’ logic, however, is the fact that they’re heavily funded by the very government whose minister they would like to see resign.

Physicians for a Smoke Free Canada, for example, is almost entirely funded by Ottawa and provincial governments. Last year, 85 per cent of its funding came directly from government. In 2020 and 2021, 97 per cent did. There is nothing necessarily wrong with organizations getting government funding, but when the money is used to aggressively lobby government for policy change, ethical questions need to be asked. Why is the government, in other words taxpayers, paying people to lobby itself? And why are certain policy viewpoints getting public support and not others?

Circular self-lobbying not only wastes taxpayer money, it also subverts democracy and erodes the concept of charity by killing charities’ independence. And it is fraudulent: it skews the public debate and political processes by masquerading circular self-lobbying as genuine civil society activism. A group of concerned doctors trying to altruistically convince Canadians to stop smoking is in reality an organization that in 2022 paid one full-time and one part-time employee a total of $104,382 in taxpayer money to lobby the government.

Government-funded NGOs and non-profits need government money because their issues don’t have widespread public support. If they did, they’d be able to fund-raise off that support. But in 2023 Physicians for a Smoke Free Canada, for instance, could only raise eight per cent of its total budget from receipted donations (with another seven per cent from “other sources,” leaving 85 per cent from government.)

Vaping isn’t risk-free. But it is much less risky than smoking — Public Health England says 95 per cent less risky. And clinical trials have shown it is a more successful quitting tool than the nicotine replacement therapies that have been on the market for decades. Research from Queen Mary University in London shows that vaping is about twice as effective as gums or patches in quitting smoking.

And flavours are a main reason vaping is a successful tool for quitting. Morethan two-thirds of vapers use vaping flavours other than tobacco-flavoured, and for good reason. They increase the likelihood of quitting smoking entirely. According to researchers at the Yale School of Public Health, vapes that aren’t tobacco-flavoured more than double the likelihood of quitting smoking.

Around 40,000 Canadians die each year from tobacco-related illnesses. Our smoking rate, though it has fallen sharply over the decades, is still about 12 per cent. You’d think an organization pushing for a “smoke-free Canada” would want to encourage more adults to access products that are exactly that, smoke-free.

Government spending money to lobby itself is perverse. The Institute For Economic Affairs in the U.K. calls the organizations that do it “sock puppets.” Should we, as taxpayers and adults, be actively funding individuals and organizations who want to police the choices we make? Absolutely not. This nefarious practice of circular lobbying needs to be ended, if not by this government then by the next.

Originally published here

Myths about vaping do more harm than good

Few topics in mental health create as much attention and misunderstanding as the rise of vaping. The mainstream media has painted a grim picture of these devices as a looming crisis, particularly for young folks, often referring to vaping products as “gateway devices”. While undoubtedly born of genuine concern, this narrative fails to acknowledge the reality of the role of vaping in tobacco harm reduction. This can unintentionally risk pushing smokers away from what can be a lifesaving alternative. When one directly examines the scientific literature on vaping, a completely different story emerges from the ones most public commentators speak of. 

Several studies conducted by authoritative sources such as Public Health England suggest that e-cigarettes are about 95 per cent less harmful than ordinary cigarettes. The effectiveness of e-cigarettes as a smoking cessation tool is another area where public perception often trails behind scientific evidence. For instance, a study published in the New England Journal of Medicine found that e-cigarettes were twice as effective at aiding smokers to quit compared to traditional nicotine replacement therapies. This finding, backed up by real-world data from countries like the United Kingdom, emphasizes the strong potential of vaping as a formidable weapon in the battle against smoking and smokingrelated diseases. As such, policy approaches that incorrectly treat vaping as equivalent to smoking or, worse, seek to ban it entirely do more harm than good.

Once celebrated as visionary, Bhutan’s attempted comprehensive tobacco ban ultimately led to a sharp growth in smoking rates and fostered a thriving black market, forcing a repeal of the policy. Similarly, South Africa’s temporary ban during the Covid-19 pandemic barely made a dent in smoking, with analyses after the fact showing that 93 per cent of South African smokers continued to practice the habit despite the ban. Moreover, rates returned to their prior values once the policy was repealed, leaving no hint of any lingering benefit. At the same time, the ban significantly increased prices of cigarettes by 240 per cent, a burden that fell disproportionately on lower-income individuals.

The unintended consequences of overly rigid policies are, thus, not mere speculation. Flavour bans, often proposed to supposedly reduce youth appeal, represent another well-intentioned but counterproductive policy. Evidence suggests that curiosity, not flavours, is the primary driver of experimentation. Furthermore, vaping flavours are key players in assisting smokers to move away from cigarettes. Hence, eliminating this option could push former smokers back to more harmful tobacco products. But by far the most pernicious myth surrounding vaping, one that has captured the minds of many policymakers (here in India included), is the “gateway effect,” which fears that young people who take up vaping will eventually end up smoking cigarettes instead.

In reality, multiple studies, like a comprehensive review of fifteen articles, fail to demonstrate any causal link between vaping and subsequent smoking initiation. Indeed, the evidence is in population numbers. Until 2016, India was the second largest tobacco consumer in the world, second only to China. However, since the advent of vaping, youth smoking rates have been at an all-time low, with a substantial 6 per cent decline in smoking rates among teens in India when vaping rates have been going up. Far from a gateway effect, these figures indicate that vapes are used as a safer alternative for cigarettes. As we navigate the intricate landscape of tobacco control in the 21st century, it’s imperative to embrace a comprehensive harm reduction approach, one that recognizes the potential of e-cigarettes as a less harmful alternative to smoking. 

Such an approach calls for nuanced policies that balance youth protection with the needs of adult smokers seeking to quit. The stakes measured in lives saved and improved are simply too high to let misinformation guide our approach to what could be one of the most significant public health innovations of our time.

Originally published here

Starmer is intent in creating more problems for himself

The government intends to introduce a ban on TV advertisements of junk food before 9 PM, a proposed tax on salt and foods high in fat, sugar and salt (HFSS), and a strengthened version of the previously failed Tobacco and Vapes Bill that extends the prohibition of smoking to outdoor space.

This comes as a set of so called preventative measures to bolster public health.

In a statement, Mike Salem, UK Associate for the Consumer Choice Center (CCC), argued that this is not the right approach to improve public health:

“Time and time again, we have seen failures of policymakers to understand what “preventative measures” actually mean. The reality is that taxing these goods will only hurt the worse off, who will continue to consume these products, at a distorted price or downgraded quality.”

Salem added that taxes on goods create a “deadweight loss”, which is a loss of welfare for everyone, including consumers, producers, and the government due to markets not reaching equilibrium.

Read the full text here

CCC Welcomes Vape Regulations, But Expresses Concern Over Effectiveness in Reducing Smoking Prevalence

KUALA LUMPUR, 4th October 2024 — The Consumer Choice Center (CCC) welcomes the newly introduced Control of Smoking Products for Public Health Act 2024 (Act 852), which seeks to regulate vape products and ensure consumer safety. However, Tarmizi Anuwar, Malaysia Country Associate at the CCC, expresses concerns over whether the regulations will achieve the desired outcome of reducing smoking prevalence, as well as the potential negative consequences for consumer choice and market competition.

“While ensuring consumer safety is vital, some of the proposed regulations, such as the retail display ban and online sales ban, could inadvertently push consumers toward unregulated markets and reduce access to safer alternatives,” said Tarmizi. “Retail displays of vape products allow consumers to make informed choices by providing transparency and fostering competition. Banning these displays will not only limit consumer awareness of vaping as an alternative to smoking but may also drive them toward less regulated and potentially unsafe options.”

Tarmizi also highlighted concerns regarding the ban on online sales, noting its disproportionate impact on small businesses and rural consumers. “The e-commerce sector is crucial for entrepreneurs and smaller players to compete with larger incumbents. Restricting online sales will isolate consumers in remote areas and stifle innovation in the market. Instead of an outright ban, the government should consider a regulatory framework that permits online sales with robust age verification measures, allowing for safer consumer access and more competitive pricing.”

The CCC believes that regulations should strike a balance between protecting public health and empowering consumers to make choices that align with their needs and preferences. While the aim of Act 852 is commendable, Tarmizi urges the government to reconsider certain restrictions and focus on policies that will have a tangible impact on reducing smoking rates while promoting safer alternatives like vaping.

A study titled Electronic Cigarettes for Smoking Cessation written by Hartmann-Boyce, J et al. (2022) found that vaping helps people quit smoking. This systematic review of 78 studies involved a total of 22,052 participants and said there is definite evidence that electronic cigarettes with nicotine increase the quit rate compared to nicotine replacement therapy and moderate certainty evidence that they increase the quit rate compared to electronic cigarettes without nicotine.

“We need to adopt an alternative that is much safer and proven effective for people who want to stop smoking. We hope to see an approach that prioritizes consumer education and product transparency, ensuring that smokers are fully informed about the benefits of harm-reduction tools like vapes,” Tarmizi concluded.

Plummeting Smoking Rates Mean a Paradigm Shift for Nicotine

In every gas station and convenience store, a new category of addictive products is flying off shelves. This new thorn in the side of public health advocates is tobacco nicotine pouches. These pouches are made of wood pulp and salt, filled with nicotine, and flavors placed under the upper lip to give the user a buzzing sensation. 

What do we make of this new nicotine rush and what it means for society? As our smoking rate declines to an all-time low of just 11 percent, it means we’re in for a paradigm shift in how we view nicotine. And we should welcome it.

On social media and Wall Street, pouches have become a craze. Politicians like Senate Majority Leader Chuck Schumer have deemed them “quiet and dangerous,” asking the FDA to crack down. Health Minister Mark Holland has banned flavored varieties in Canada and restricted their sales to only pharmacies. And nicotine products have become a cultural fixation heralded by GOP members of Congress, broadcaster Tucker Carlson, and the political campaign of Republican vice-presidential nominee JD Vance.

With people more aware of the harmful effects of smoking cigarettes, adult smokers have begun shifting their addictions to products deemed less risky. Entrepreneurs and tobacco firms have delivered on this trend, but public institutions have been less tactful in response.

Alternative nicotine products like vaping devices, gums and pouches have markedly lower risk than cigarettes. They could help save some of the hundreds of thousands of lives lost to smoking illnesses each year. Despite the scientific evidence in favor of alternative nicotine products, the FDA continues to be outdated and obstinate. The FDA regulates vaping devices and pouches as “tobacco products” — even though they do not contain tobacco.

The FDA’s Premarket Tobacco Product Application restricts sales of these new products, forcing firms to endure a byzantine application and review process that is insurmountable for any small business. Of the nearly 27 million applications, just 34 vaping devices or nicotine alternatives have been authorized, all of which are primarily products of tobacco firms that can afford the compliance costs.

And while perceptions across health and political establishments sour on the utility of these products, and make them less available to adults, they’ve also become captive to outright misinformation.

A 2020 study in the Journal of General Internal Medicine revealed that more than 80 percent of U.S. physicians surveyed wrongly believe that “nicotine causes cancer” rather than smoking itself. According to a recent Gallup survey, 79 percent of Americans believe cigarettes are very harmful, and 57 percent say the same about vaping devices. That number dips to 34 percent for nicotine pouches.

Public health institutions have contributed to these false perceptions, buoyed by a vibrant industry of philanthropists who would prefer to outlaw nicotine altogether. While youth access to nicotine products should continue to be of paramount concern to regulators, we should also recognize that technological innovation has delivered a less harmful way for adults to use nicotine once they’re addicted.

It’s time our institutions reflect this reality.

First, the FDA must communicate to adults the truth about nicotine alternatives to traditional tobacco products. Whether it’s pouches or flavored nicotine vaping devices, the risk of using these products would be significantly lower.

Second, governments should tax lower-risk nicotine products less. Pouches and vaping products should not be taxed the same as cigarettes. If sin taxes are here to stay, they should at least be proportionate and nudge consumers toward less risky products.

This has been the approach of countries such as Sweden, which now boasts some of the lowest smoking-related illness rates in the world.

Third, in the private sector, the health and insurance industries must accept the risk profile of the new generation of nicotine products and recalibrate their plans. Many health and life insurance policies still equate smoking cigarettes with using non-tobacco nicotine products. That practice should change to reflect scientific reality and facts.

Misguided public policy forces adult smokers to choose between an arbitrarily limited number of legal options, many of which are decades-old legacy products, the rampant illicit market for illegal disposable vapes and nicotine pouches, or continuing to smoke cigarettes.

When they do switch, our institutions are set up to continue to punish them with higher taxes and insurance policies. This cannot stand. As our culture updates its perception of nicotine, we should make sure our policies do the same. That is the best way to save lives and lower healthcare costs for most people.

Originally published here

en_USEN

Follow us

WASHINGTON

712 H St NE PMB 94982
Washington, DC 20002

BRUSSELS

Rond Point Schuman 6, Box 5 Brussels, 1040, Belgium

LONDON

Golden Cross House, 8 Duncannon Street
London, WC2N 4JF, UK

KUALA LUMPUR

Block D, Platinum Sentral, Jalan Stesen Sentral 2, Level 3 - 5 Kuala Lumpur, 50470, Malaysia

OTTAWA

718-170 Laurier Ave W Ottawa, ON K1P 5V5

© COPYRIGHT 2025, CONSUMER CHOICE CENTER

Also from the Consumer Choice Center: ConsumerChamps.EU | FreeTrade4us.org